The Mark Foundation: Day 2 of Mark Symposium on Novel Cancer Therapies
The Mark Foundation for Cancer Research/X

The Mark Foundation: Day 2 of Mark Symposium on Novel Cancer Therapies

The Mark Foundation for Cancer Research shared a post on X:

“We’re back with Day 2 of Mark Symposium! Our first session, on novel cancer therapies, featured a powerhouse lineup including William Sellers (The Sellers Lab), Aashish Manglik, and Julien Sage. The future of targeted treatment is bright.”

The Mark Foundation

Other articles about The Mark Foundation on OncoDaily.